Endocrine Abstracts

Background: UPEA for LRR in PTC was introduced in 1993 (JCEM 96:2717, 2011). It is not appreciated that such non-invasive ablations can often be repeated over decades (Surgery 154:1448, 2013). Skin metastases (SM) from thyroid carcinoma are typically associated with disseminated disease; average survival after SM diagnosis is 19 months (JAAD 36:531, 1997). Our case provides insights into managing LRR and SM in LRPTC.Clinical case: In 2004, an open biopsy...

Introduction: Ethanol ablation (EA) of “persistent or recurrent” neck nodal metastases (NNM) in adult papillary thyroid carcinoma (APTC) patients was first introduced in 1993 to clinical endocrine oncologic practice (JCEM 2011;96: 2717). At Mayo Clinic we have been impressed by the efficacy of EA in controlling postoperative NNM in stage I APTC patients. We now describe the long-term outcome results of EA in controlling recurrent NNM in 41 patients consecutively mana...

Introduction: Childhood papillary thyroid carcinoma (CPTC), despite bilateral thyroidectomy (BT), nodal resection and radioiodine remnant ablation (RRA), recurs within neck nodal metastases (NNM) in >30% within 20 postoperative years. However, these NNM are usually treated with re-operation or further radioiodine; US-guided ethanol ablation (EA) may be considered (j.sempedsurg.2020.150920) for patients with limited numbers of NNMMethods: We studied l...